Optimal drug combinations and minimal hitting sets
- PMID: 19660129
- PMCID: PMC2738654
- DOI: 10.1186/1752-0509-3-81
Optimal drug combinations and minimal hitting sets
Abstract
Background: Identifying effective drug combinations that significantly improve over single agents is a challenging problem. Pairwise combinations already represent a huge screening effort. Beyond two drug combinations the task seems unfeasible.
Results: In this work we introduce a method to uncover drug combinations with a putative effective response when presented to a heterogeneous population of malignant agents (strains), such as cancer cell lines or viruses. Using data quantifying the effect of single drugs over several individual strains, we search for minimal drug combinations that successfully target all strains. We show that the latter problem can be mapped to a minimal hitting set problem in mathematics. We illustrate this approach using data for the NCI60 panel of tumor derived cell lines, uncovering 14 anticancer drug combinations.
Conclusion: The drug-response graph and the associated minimal hitting set method can be used to uncover effective drug combinations in anticancer drug screens and drug development programs targeting heterogeneous populations of infectious agents such as HIV.
Figures



Similar articles
-
A pan-cancer screen identifies drug combination benefit in cancer cell lines at the individual and population level.Cell Rep Med. 2024 Aug 20;5(8):101687. doi: 10.1016/j.xcrm.2024.101687. Cell Rep Med. 2024. PMID: 39168097 Free PMC article.
-
Large-scale Pan-cancer Cell Line Screening Identifies Actionable and Effective Drug Combinations.Cancer Discov. 2024 May 1;14(5):846-865. doi: 10.1158/2159-8290.CD-23-0388. Cancer Discov. 2024. PMID: 38456804 Free PMC article.
-
Biological insights into effective and antagonistic combinations of targeted agents with chemotherapy in solid tumors.Cancer Metastasis Rev. 2014 Mar;33(1):295-307. doi: 10.1007/s10555-013-9451-7. Cancer Metastasis Rev. 2014. PMID: 24338003 Review.
-
Implementation of the NCI-60 Human Tumor Cell Line Panel to Screen 2260 Cancer Drug Combinations to Generate >3 Million Data Points Used to Populate a Large Matrix of Anti-Neoplastic Agent Combinations (ALMANAC) Database.SLAS Discov. 2019 Mar;24(3):242-263. doi: 10.1177/2472555218812429. Epub 2018 Nov 30. SLAS Discov. 2019. PMID: 30500310
-
JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs.Bioorg Med Chem. 2012 Mar 15;20(6):1947-51. doi: 10.1016/j.bmc.2012.01.017. Epub 2012 Jan 21. Bioorg Med Chem. 2012. PMID: 22336246 Review.
Cited by
-
Combinatorial therapy discovery using mixed integer linear programming.Bioinformatics. 2014 May 15;30(10):1456-63. doi: 10.1093/bioinformatics/btu046. Epub 2014 Jan 24. Bioinformatics. 2014. PMID: 24463180 Free PMC article.
-
Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review.Pharmacol Ther. 2013 Jun;138(3):333-408. doi: 10.1016/j.pharmthera.2013.01.016. Epub 2013 Feb 4. Pharmacol Ther. 2013. PMID: 23384594 Free PMC article. Review.
-
Allele-specific p53 mutant reactivation.Cancer Cell. 2012 May 15;21(5):614-625. doi: 10.1016/j.ccr.2012.03.042. Cancer Cell. 2012. PMID: 22624712 Free PMC article.
-
Analysis of the robustness of network-based disease-gene prioritization methods reveals redundancy in the human interactome and functional diversity of disease-genes.PLoS One. 2014 Apr 14;9(4):e94686. doi: 10.1371/journal.pone.0094686. eCollection 2014. PLoS One. 2014. PMID: 24733074 Free PMC article.
-
Critical controllability in proteome-wide protein interaction network integrating transcriptome.Sci Rep. 2016 Apr 4;6:23541. doi: 10.1038/srep23541. Sci Rep. 2016. PMID: 27040162 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources